News : Industry

FinFET and FD-SOI are currently neck-and-neck in the race to further miniaturize CMOS circuits beyond the 28 nm node. And major market players will play a key role in determining which technology wins. Leti, which has been betting on FD-SOI for years now, recently joined the 22FDXAccelerator ecosystem created by GlobalFoundries, the world’s second-largest foundry. […] >>

UroMems, a startup founded in 2011 and housed at the BHT, has just completed a very impressive round of fundraising, bringing in €14 million in fresh capital. The company’s product—an artificial urinary sphincter implant that can be placed near the urethra—is a breakthrough innovation that could potentially help the 50 million people worldwide currently suffering […] >>

MIT used Leti’s suspended micro-resonators to develop a new microchip for fast drug testing. The chip measures cell culture growth by weighing the culture with accuracy to within a femtogram. The measurement provides an indication of the culture’s response to a drug such as an antibiotic. The results of the research were published in Nature […] >>

What is Leti’s strategy for CES 2017? Our booth will be twice as big as last year’s. We will showcase three interactive demonstrator systems that will let visitors experience and test our technologies and understand the technologies’ features. Three startups will be coming with us: e-Lichens, with us in 2016; Moovlab, which was just created; […] >>

In the future, major structures like bridges, dams, tunnels, railroad tracks, oceangoing vessels, cooling towers, and wind-turbine blades could be instrumented with Morphosense’s MEMS accelerometer networks. Morphosense is a Leti spinoff founded in mid-2016 to develop a precision structural-health monitoring system leveraging ten years of R&D. The system, which consists of sensors mounted at strategic […] >>